Skip to content
NB
Company

Updated:

NEXIEN BIOPHARMA, INC.

NEXIEN BIOPHARMA, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001625288, and its reported industry...

Overview

NEXIEN BIOPHARMA, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001625288, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-10-22, it reported net income of USD -239,113; total assets of USD 4,183 for the fiscal period ended 2024-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
NEXIEN BIOPHARMA, INC.
Former names in filing history
Intiva BioPharma Inc. (2017-11-29 to 2018-09-12); Kinder Holding Corp. (2014-11-14 to 2017-11-06)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Glendale, CO, United States
Incorporated in
DE
Fiscal year end
June 30
SEC CIK
0001625288

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2024USD-$239,113$4,183$4,183-$64,364
FY2023USD-$361,902$43,127$35,147-$81,751
FY2022USD-$626,357$124,518—-$75,143
FY2021USD-$1.9M$25,541$18,041-$90,745

Recent SEC filings

FormFiledPeriodFiling
10-Q10-Q
10-QForm 10-Q
10-QForm 10-Q
10-KForm 10-K
10-QForm 10-Q
10-QForm 10-Q
10-QForm 10-Q
10-KForm 10-K
10-QForm 10-Q
10-QForm 10-Q
10-QForm 10-Q
10-KForm 10-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research NEXIEN BIOPHARMA, INC. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

NEXIEN BIOPHARMA, INC. | Glendale Company | Altss